Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alyssa Cendagorta"'
Autor:
Kevin C. Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J. Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 793-797 (2024)
Abstract Teclistamab is a B‐cell maturation antigen (BCMA)‐directed bispecific T‐cell engager approved for relapsed‐refractory multiple myeloma (RRMM). Cytokine release syndrome (CRS) and Immune effector cell‐associated neurotoxicity syndro
Externí odkaz:
https://doaj.org/article/52d53d0c9d374fbfa2c3a623e2dafa7c
Autor:
James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Publikováno v:
Blood.
COVID-19 still represents a major issue for patients with lymphoid malignancies, especially those on therapy, because of immune suppression and suboptimal responses to vaccination. Davis et al report on their experience with double dose tixagevimab-c
Autor:
Aswani Thurlapati, Kiera Roubal, James A. Davis, Syed Z. Shah, Deidra Smith, Mary McGann, Kelly Gaffney, Alyssa Cendagorta, Andy Maldonado, Erin Weeda, Hamza Hashmi
Publikováno v:
Transplantation and Cellular Therapy. 29:340.e1-340.e4